-
GLOCKNER-5
Symptomatic treatment of thyrotoxicosis (including Graves-Basedow’ disease). Treatment of hyperthyroidism in preparation for thyroidectomy until the basal metabolism rate return to normal to prevent possible… -
GON SA ATZETI
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due… -
GON SA EZETI-10
Primary Hypercholesterolaemia: Ezetimibe co-administered with an HMG-CoA reductase inhibitor (statin) is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial… -
GOURCUFF-2.5
Treatment of the functional symptoms of benign prostatic hyperplasia (BPH). This is only the preview. Please check here for the full indication. -
GOURCUFF-5
Treatment of the functional symptoms of benign prostatic hyperplasia (BPH). This is only the preview. Please check here for the full indication. -
HAYEX
Management of asthma, bronchospasm and/or reversible airways obstruction. This is only the preview. Please check here for the full indication. -
HUNTELAAR-2
Lacidipine is indicated in adults for the treatment of hypertension either alone or in combination with other antihypertensive agents, including ß-adrenoceptor antagonists, diuretics, and ACE-inhibitors… -
JAVIEL
Treatment of symptoms in patients with osteoarthritis of the hip or knee, with delayed effect. Treatment with diacerein is not recommended in patients with rapidly… -
JIMENEZ
HIV-1 infection Tenofovir is indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected adults. Tenofovir is also indicated for the…